Informal start. People check their camera, connection, etc

Welcome

SESSION 1
Phylogenesis and evolution of pathogenic beta-coronaviruses

Chair: Federico Manuel Giorgi (Bologna)

Edward C. Holmes (The University of Sydney, NSW, Australia)
Zoonoses and the Emergence of COVID-19

Graziano Pesole (University of Bari Aldo Moro, Italy)
Comparative and Evolutionary Genomics of SARS-Cov-2

Daniele Mercatelli (University of Bologna, Italy)
Coronapp, a web tool for fast and easy tracking of SARS-CoV-2 evolution

SESSION 2
Viral life cycle and structural biology

Chair: Martino Bolognesi (Milan)

Martin Walsh (Diamond Light Source, Didcot, UK)
Crystallographic fragment screening of the SARS-CoV-2 main protease (and more..)

Ralf Bartenschlager (University of Heidelberg, Germany)
Insights into the SARS-CoV-2 replication cycle and implications for antiviral therapy

Caterina La Porta (University of Milan, Italy)
Heterogeneity of coronavirus peptide binding across human haplotypes

SESSION 3
Therapeutic strategies

Chair: Gianni Sava (Trieste)

Johan Neyts (Rega Institute for Medical Research, KU Leuven, Belgium)
Towards the development of antivirals against SARS-CoV2 and future pandemic preparedness

Annalisa Capuano (Università degli Studi della Campania "Luigi Vanvitelli", Italy)
Covid-19: The pros and cons of high-speed science

Valentina Giudice (University of Salerno, Italy)
Preliminary results from a controlled study using ruxolitinib and eculizumab for treatment of severe SARS-CoV-2-related acute respiratory distress syndrome

SESSION 4
Adaptive immunity and vaccines

Chair: Gennaro Ciliberto (Rome)

Andrea Carfì (ModeRNA Inc., Cambridge, MA, USA)
Rapid development of mRNA-1273: a vaccine against SARS-CoV-2

Antonio Lanzavecchia (INGM, Milan, Italy)
Antibody-guided vaccine design

Luigi Aurisicchio (Takis srl, Italy)
COVID-eVax: an innovative vaccine platform based on genetic engineering and DNA electroporation

SESSION 5
Virus-host cell interactions

Chair: Valeria Poli (Turin)

Susan Weiss (University of Pennsylvania, Philadelphia, PA, USA)
Coronavirus antagonism of double-stranded RNA induced antiviral pathways

Dmitry Korkin (Worcester Polytechnic Institute, MA, USA)
Structural genomics of SARS-CoV-2 to determine the knowledge of viral envelope: moving a step closer to modeling viral-host interaction

Gianni Cesareni (University of Rome Tor Vergata)
The SARS-Cov-2 functional map

SESSION 6
Markers of diagnosis and pathology

Chair: Raffaele de Francesco (Milan)

Andrea Crisanti (University of Padua, Italy) CANCELLED
Suppression of COVID-19 outbreak in the municipality of Vo’, Italy

Viviana Simon (Icahn School of Medicine at Mount Sinai, New York, NY, USA)
SARS-CoV2 in the City: Surveillance in New York City

Melanie Ott (University of California San Francisco, CA, USA)
COVID-19 Diagnostic Directions: Time vs Sensitivity

Salvatore Sciacchitano (Sapienza University of Rome, Italy)
Is there any link between the new SARS-CoV-2 infection and the old Low T3 syndrome?